Xenetic Biosciences, Inc. (XBIO) stock
XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3067% below fair value
$1.61+0.12 (+8.05%)
Close on Nov 17, 2026Market cap $3.77MP/E –Yield –
Xenetic Biosciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Xenetic Biosciences's ebitda for the twelve months ending Dec 31, 2021 was -$5.75M. For fiscal 2022 it was -$6.72M. The highest annual figure on record is -$5.75M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$6.72M | – |
| FY2021 | Dec 31, 2021 | -$5.75M | – |
| FY2020 | Dec 31, 2020 | -$13.94M | – |
| FY2015 | Dec 31, 2015 | -$9.77M | – |
| FY2014 | Dec 31, 2014 | -$12.84M | – |
| FY2013 | Dec 31, 2013 | -$8.56M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | -$1.87M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.38M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.13M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.22M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.50M | – |
| Q2 FY2020 | Jun 30, 2020 | -$982.26K | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.24M | – |
| Q2 FY2016 | Jun 30, 2016 | -$43.25M | – |
See a number that looks wrong?